A novel bone substitute composite composed of tricalcium phosphate, gelatin and drynaria fortunei herbal extract

Journal of Biomedical Materials Research - Part A

Volumn 84, Issue 1, 2008, Pages 167-177

  Dong, Guo Chung ^a   Hueih, Min Chen ^b,c   Yao, Chun Hsu ^d  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

^c NATIONAL NANO DEVICE LABORATORIES   (Taiwan)

^d CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Animal model; Cell culture; Chinese herbal medicine; Composite hard tissue; Tissue culture

Indexed keywords

BONE SUBSTITUTES; DRYNARIA FORTUNEI; TRICALCIUM PHOSPHATE;

BIOACTIVITY; BIOASSAY; BIODEGRADATION; BONE; OSTEOBLASTS; RATS; TISSUE CULTURE;

PLANTS (BOTANY);

CALCIUM PHOSPHATE; DRYNARIA FORTUNEI EXTRACT; GELATIN; HERBACEOUS AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE CELL; BONE REGENERATION; CELL CULTURE; COLORIMETRY; COMPOSITE MATERIAL; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OSTEOBLAST; POLYPODIACEAE; RAT;

ANIMALS; ANIMALS, NEWBORN; BONE SUBSTITUTES; CALCIUM PHOSPHATES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; GELATIN; OSTEOBLASTS; PLANT EXTRACTS; POLYPODIACEAE; RATS; RATS, SPRAGUE-DAWLEY; TISSUE CULTURE TECHNIQUES;

EID: 36949041076     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31261     Document Type: Article

References (36)

1. Kikuchi M, Itoh S, Ichinose S, Shinomiya K, Tanaka J. Self-organization mechanism in a bone-like hydroxyapatite/collagen nanocomposite synthesized in vitro and its biological reaction in vivo. Biomaterials 2001;22:1705-1711.
2. Damien CJ, Parsons JR. Bone graft and bone graft substitutes: A review of current technology and applications. J Appl Biomater 1991;2:187-208.
3. Kocialkowski A, Wallace WA, Burwell RG. Collagraft combined with autogeneic bone marrow: Experimental and clinical results. In: Urist MR, O'Connor BT, Burwell RG, editors. Bone Grafts, Derivatives and Substitutes. London: B.H. Ltd.; 1994. p 271-290.
4. Grynpas MD, Pilliar RM, Kandel RA, Renlund R, Filiaggi M, Dumitriu M. Porous calcium polyphosphate scaffolds for bone substitute applications in vivo studies. Biomaterials 2002;23:2063-2070.
5. Lee JY, Nam SH, Im SY, Park YJ, Lee YM, Seol YJ, Chung CP, Lee SJ. Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials. J Controlled Release 2002;78:187-197.
6. Liu BS, Yao CH, Chen YS, Hsu SH. In vitro evaluation of degradation and cytotoxicity of a novel composite as a bone substitute. J Biomed Mater Res A 2003;67:1163-1169.
7. Yao CH, Liu BS, Hsu SH, Chen YS, Tsai CC. Biocompatibility and biodegradation of a bone composite containing tricalcium phosphate and genipin crosslinked gelatin. J Biomed Mater Res A 2004;69:709-717.
8. Yao CH, Liu BS, Chang CJ, Hsu SH, Chen YS. Preparation of networks of gelatin and genipin as degradable biomaterials. Mater Chem Phys 2004;83:204-208.
9. Yao CH, Liu BS, Hsu SH, Chen YS. Calvarial bone response to a tricalcium phosphate-genipin crosslinked gelatin composite. Biomaterials 2005;26:3065-3074.
10. Koh HL, Woo SO. Chinese proprietary medicine in Singapore: Regulatory control of toxic heavy metals and undeclared drugs. Drug Saf 2000;23:351-362.
11. Chan K. Progress in traditional Chinese medicine. Trends Pharmacol Sci 1995;16:182-187.
12. Yuan R, Lin Y. Traditional Chinese medicine: An approach to scientific proof and clinical validation. Pharmacol Ther 2000;86:191-198.
13. Arnold MD, Thornbrough LM. Treatment of musculoskeletal pain with traditional Chinese herbal medicine. Phys Med Rehabil Clin N Am 1999;10:663-671. ix-x.
14. Yao CH, Tsai CC, Chen YS, Chang CJ, Liu BS, Lin CC, Tsuang YH. Fabrication and evaluation of a new composite composed of tricalcium phosphate, gelatin and chi-li-saan as a bone substitute. Am J Chin Med 2002;30:471-482.
15. Lin FH, Dong GC, Chen KS, Jiang GJ, Huang CW, Sun JS. Immobilization of Chinese herbal medicine onto the surface-modified calcium hydrogen phosphate. Biomaterials 2003;24:2413-2422.
16. Sun JS, Lin CY, Dong GC, Sheu SY, Lin FH, Chen LT, Wang YJ. The effect of Gu-Sui-Bu (Drynaria fortunei J. Sm) on bone cell activities. Biomaterials 2002;23:3377-3385.
17. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Martin TJ, Suda T. Osteoblastic cells are involved in osteoclast formation. Endocrinology 1988;123:2600-2602.
18. Sato T, Morita I, Murota S. Involvement of cholesterol in osteoc last-like cell formation via cellular fusion. Bone 1998;23:135-140.
19. Sun JS, Chang WS, Hong RC, Hung TY, Lin FH, Liu HC. Alveolar mononuclear cells can develop into multinucleated osteoclasts: An in vitro cell culture model. J Biomed Mater Res 2000;52:142-147.
20. Vrouwenvelder WC, Groot CG, de Groot K. Behaviour of fetal rat osteoblasts cultured in vitro on bioactive glass and nonreactive glasses. Biomaterials 1992;13:382-392.
21. Lin CY, Sun JS, Sheu SY, Lin FH, Wang YJ, Chen LT. The effect of Chinese medicine on bone cell activities. Am J Chin Med 2002;30:271-285.
22. Hofman S, Sidqui M, Abensur D, Valentini P, Missika P. Effects of Laddec on the formation of calcified bone matrix in rat calvariae cells culture. Biomaterials 1999;20:1155-1166.
23. Ciapetti G, Ambrosio L, Savarino L, Granchi D, Cenni E, Baldini N, Pagani S, Guizzardi S, Causa F, Giunti A. Osteoblast growth and function in porous poly e-caprolactone matrices for bone repair: A preliminary study. Biomaterials 2003;24:3815-3824.
24. Minkin C. Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 1982;34:285-290.
25. Liu HC, Yao CH, Sun JS, Lee CJ, Huang CW, Lin FH. Osteogenic evaluation of glutaraldehyde crosslinked gelatin composite with fetal rat calvarial culture model. Artif Organs 2001;25:644-654.
26. Laffargue P, Fialdes P, Frayssinet P, Rtaimate M, Hildebrand HF, Marchandise X. Adsorption and release of insulin-like growth factor-I on porous tricalcium phosphate implant. J Biomed Mater Res 2000;49:415-421.
27. Tabata Y, Nagano A, Muniruzzaman M, Ikada Y. In vitro sorption and desorption of basic fibroblast growth factor from biodegradable hydrogels. Biomaterials 1998;19:1781-1789.
28. Kim HD, Valentini RF. Human osteoblast response in vitro to platelet-derived growth factor and transforming growth factor-β delivered from controlled-release polymer rods. Biomaterials 1997;18:1175-1184.
29. Huang HF, You JS. The use of Chinese herbal medicine on experimental fracture healing. Am J Chin Med 1997;25:351-356.
30. Ma KC, Zhu TY, Wang FX. Stimulative effects of gusuibu (Drynaria baronii) injection on chick embryo bone primordium calcification in vitro. Am J Chin Med 1996;24:77-82.
31. Manson PN, Crawley WA, Hoopes JE. Frontal cranioplasty: Risk factors and choice of cranial vault reconstructive material. Plast Reconstr Surg 1986;77:888-904.
32. Holmes RE, Hagler HK. Porous hydroxyapatite as a bone graft substitute in cranial reconstruction: A histometric study. Plast Reconstr Surg 1988;81:662-671.
33. Harvey WK, Pincock JL, Matukas VJ, Lemons JE. Evaluation of a subcutaneously implanted hydroxylapatite-avitene mixture in rabbits. J Oral Maxillofac Surg 1985;43:277-280.
34. Rawlings CE, Wilkins RH 3rd, Hanker JS, Georgiade NG, Harrelson JM. Evaluation in cats of a new material for cranioplasty: A composite of plaster of Paris and hydroxylapatite. J Neurosurg 1988;69:269-275.
35. Frame JW. A convenient animal model for testing bone substitute materials. J Oral Surg 1980;38:176-180.
36. Schmitz JP, Hollinger JO. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res 1986;205:299-308.